Healthcare professionals and patient groups have written to Vertex’s CEO Jeffrey Leiden in a bid to resolve a funding row over cystic fibrosis drugs, as UK MPs prepare to hold a public hear
US pharmacy benefits manager CVS Health Corp has added new migraine drugs from Teva and Eli Lilly to its list of covered drugs but excluded a rival from Amgen, according to a press report.<
While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug has received a label extension from the European Commission allowing it to be used in you
The future of Sanofi and Lexicon’s oral diabetes drug Zynquista hangs in the balance after an FDA advisory committee was split on whether the drug would benefit patients.